Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-17 3:05 pm Sale | 13G | ARQULE INC ARQL | Consonance Capital Management LP | 0 0% | -6,058,505![]() (Position Closed) | View |
2021-02-16 2:19 pm Sale | 13G | ARQULE INC ARQL | Consonance Capital Management LP | 6,058,505 11% | -679,701![]() (-10.09%) | View |
2020-02-14 5:00 pm Sale | 13G | ARQULE INC ARQL | BIOTECHNOLOGY VALUE FUND L P | 4,902,383 4% | -3,767,967![]() (-43.46%) | View |
2020-02-14 12:19 pm Purchase | 13G | ARQULE INC ARQL | Consonance Capital Management LP | 6,738,206 5.56% | 6,738,206![]() (New Position) | View |
2020-02-12 5:02 pm Sale | 13G | ARQULE INC ARQL | INTEGRATED CORE STRATEGIES (US) LLC | 1,308,382 1.1% | -4,160,435![]() (-76.08%) | View |
2020-02-12 12:04 pm Purchase | 13G | ARQULE INC ARQL | VANGUARD GROUP INC | 5,917,567 4.89% | 451,709![]() (+8.26%) | View |
2020-02-10 1:42 pm Sale | 13G | ARQULE INC ARQL | Nantahala Capital Management LLC | 0 0% | -6,544,347![]() (Position Closed) | View |
2020-02-05 11:25 am Purchase | 13G | ARQULE INC ARQL | BlackRock Inc. BLK | 10,009,684 8.3% | 1,391,672![]() (+16.15%) | View |
2020-01-10 4:01 pm Sale | 13G | ARQULE INC ARQL | Nantahala Capital Management LLC | 6,544,347 5.4% | -6,092,775![]() (-48.21%) | View |
2020-01-09 4:15 pm Sale | 13G | ARQULE INC ARQL | Bleichroeder LP | 2,750,000 2.28% | -13,178,628![]() (-82.74%) | View |
2019-12-16 5:12 pm Purchase | 13D | ARQULE INC ARQL | Merck & Co. Inc. MRK | 17,481,903 12.6% | 17,481,903![]() (New Position) | View |
2019-09-19 12:47 pm Purchase | 13D | ARQULE INC ARQL | Pontifax Management 4 G.P. (2015) Ltd. | 8,844,587 7.35% | 452,587![]() (+5.39%) | View |
2019-09-06 08:44 am Unchanged | 13G | ARQULE INC ARQL | Bleichroeder LP | 15,928,628 13.25% | 0 (Unchanged) | View |
2019-09-05 4:48 pm Purchase | 13G | ARQULE INC ARQL | Bleichroeder LP | 15,928,628 13.25% | 15,928,628![]() (New Position) | View |
2019-09-04 4:48 pm Sale | 13G | ARQULE INC ARQL | First Eagle Investment Management LLC | 0 0% | -16,081,128![]() (Position Closed) | View |
2019-05-13 4:13 pm Purchase | 13G | ARQULE INC ARQL | INTEGRATED CORE STRATEGIES (US) LLC | 5,468,817 5% | 1,421,591![]() (+35.13%) | View |
2019-03-15 9:36 pm Sale | 13G | ARQULE INC ARQL | 1Globe Capital LLC | 426,501 0.39% | -3,529,670![]() (-89.22%) | View |
2019-02-14 4:51 pm Sale | 13G | ARQULE INC ARQL | BIOTECHNOLOGY VALUE FUND L P | 8,670,350 7.8% | -3,406,494![]() (-28.21%) | View |
2019-02-14 10:56 am Sale | 13G | ARQULE INC ARQL | Nantahala Capital Management LLC | 12,637,122 11.5% | -120,251![]() (-0.94%) | View |
2019-02-11 2:19 pm Purchase | 13G | ARQULE INC ARQL | First Eagle Investment Management LLC | 16,081,128 14.75% | 1,347,644![]() (+9.15%) | View |